[The diagnostic and prognostic significance of ketonuria in fertility disorders of cattle]. / Die diagnostische und prognostische Bedeutung der Ketonurie bei den Fruchtbarkeitsstörungen des Rindes.

The diagnostic and prognostic significance of ketonuria for the prognosis of reproductive disorders in high-performance dairy cows was examined in 3 herds of Holstein Friesian and Holstein Friesian x Hungarian Red Pied F1 that were either primiparae or were due to calve for the 2nd to 8th time during the study period from mid-February to late March, 1988. The course of uterine involution and status of the ovaries was followed up by regular rectal and vaginal examination. In the first experiment (n = 15) the return of cyclic ovarian activity was monitored by determination of progesterone in milk twice weekly over a period of 10 weeks post partum. In the second experiment (n = 121) urine and milk samples were collected at intervals of 5 to 8 days over a period of 9 weeks post partum and analysed for ketone bodies. The body condition of the cows was estimated by a scoring system at 5 and 9 weeks post partum. In the third experiment (n = 289) urine samples taken 1-4 days before as well as 3 days and 5 weeks after calving were analysed for ketone bodies. Biologic reproduction data were followed up for 150 days post partum in all experiments. One to two thirds of the cows in the examined herds showed ketonuria post partum, some animals also displayed ketonuria ante partum. Persistent postpartal ketonuria occurred mainly among the older cows with a high performance that at the same time showed a marked loss of body condition during the first weeks post partum. Primiparous heifers seldom developed ketonuria, despite a generally poor body condition.(ABSTRACT TRUNCATED AT 250 WORDS)

Improvement of four patients with HIV-1 related symptoms after hyperimmunization with killed poliomyelitis (Salk) vaccine.

Four HIV-1 positive patients with characteristic symptoms of this infection experienced amelioration or resolution of symptoms after 2 months of hyperimmunization with inactivated (Salk) poliomyelitis vaccine. The patient who was initially the most symptomatic exhibited a marked improvement in T4/T8 ratio at the sixth month of continued hyperimmunization treatment. With two patients reported previously, six consecutive patients with lymphotropic retrovirus disease have benefited from hyperimmunization with inactivated polio vaccine.

Clinical usefulness of sodium amobarbital interviewing.

We report a double-blind, randomized, placebo-controlled study utilizing a within-subjects design on 20 hospitalized, psychiatric patients who participated in sodium amobarbital interviews to determine if the drug has a specific effect in eliciting clinically useful information. The patients selected had difficulty communicating with their primary therapists during the postadmission, diagnostic interviews. Two raters completed a Hamilton Depression Scale, a New Haven Schizophrenia Index, and a Brief Psychiatric Rating Scale after each interview. Although both the amobarbital and saline interviews were moderately useful in obtaining new information, we found no significant difference in the primary therapists' assessments of clinical usefulness. In addition, the drug interview did not uncover material that would aid in the differential diagnosis between depression and schizophrenia. There was, however, a significant negative correlation between the assessment of general usefulness and the time interval between admission and interviewing. We report our only exception, a case of catatonic schizophrenia, in which the patient responded specifically to the drug.

Effects of dopamine agonists in tardive dyskinesia.

The authors used a combined behavioral and neuroendocrinological strategy to investigate the relevance of abnormalities in the brain dopaminergic systems to the pathophysiology of tardive dyskinesia by assessing the effects of apomorphine, a directly acting dopamine agonist, and d-amphetamine, an indirectly acting dopamine agonist, in patients with tardive dyskinesia. Administration of I.V. d-amphetamine increased dyskinetic movements in most patients with tardive dyskinesia, a finding consistent with the dopaminergic hypothesis. Contrary to predictions based on animal models, apomorphine did not increase dyskinetic movements in these patients but instead substantially reduced dyskinesia in some patients. Patients with tardive dyskinesia did not have a greater drop in serum prolactin or a greater rise in serum growth hormone after apomorphine than normal or chronic schizophrenic subjects without tardive dyskinesia.

Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions.

Pharmacokinetics of the phenothiazine, butaperazine, were studied in relationship to acute dystonic reactions. Dystonias appeared on falling drug concentrations, more than one half-life after plasma and red blood cell (RBC) peak butaperazine concentrations. Red blood cell butaperazine kinetics differentiated better than did plasma butaperazine levels those subjects in whom dystonias would develop from those in whom they did not. We conclude that RBC phenothiazine levels may more clearly reflect drug concentration at critical brain sites than do simple plasma drug levels. Furthermore, dystonic reactions may be the result of differential sensitivity of two or more receptor systems to receptor blockade by antischizophrenic agents.

Dystonic reactions following neuroleptics: time course and proposed mechanisms.

The occurrence of acute dystonic reactions was studied relative to drug pharmacokinetic parameters following a single dose of the phenothiazine, butaperazine. Dystonias occurred more than one half-life from peak butaperazine levels, 23 to 56 h after drug administration. The authors postulate that the appearance of dystonias on falling plasma concentrations may be due to disruption of dopaminergic-cholinergic balance caused by differential antidopaminergic and anticholinergic potencies of the drug.